BRIAN BOWMAN: Open Payments
NPI 1770971418 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 13 payments from 8 companies in 2025. Trend: 2023 $465 · 2024 $878 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $86 |
| ABBVIE INC. | 3 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $33 |
| Genentech USA, Inc. | 1 | $29 |
| Incyte Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $16 |
| Janssen Biotech, Inc. | 1 | $15 |
Products named: SCEMBLIX, Venclexta, EPKINLY, CALQUENCE, GIVLAARI, JAKAFI, JAYPIRCA, DARZALEX.
Industry payments across CA — which companies pay providers there.
